The National Cholesterol Education Program
- 23 December 1998
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 280 (24) , 2099-2104
- https://doi.org/10.1001/jama.280.24.2099
Abstract
The National Cholesterol Education Program (NCEP) is a prime example of the role the National Heart, Lung, and Blood Institute has played, in its 50 years of existence, as a catalyst for translating research advances into improved clinical and public health practices. Since its inception in 1985, the NCEP has adhered to 2 principles in mounting educational campaigns for professionals and the public: building on a strong science base and working in partnership with other organizations. In slightly more than a decade, the NCEP has made significant progress toward its goal of reducing the prevalence of high blood cholesterol. The impact of cholesterol education is clearly visible in 4 major trends: increasing professional and public cholesterol awareness; declining dietary intakes of saturated fat, total fat, and cholesterol; falling serum cholesterol levels; and a continuing decline in coronary heart disease (CHD) mortality rates. Nevertheless, cholesterol levels are still being undertreated, especially in patients with CHD, and substantial scientific and educational challenges remain. As it looks forward to the 21st century, the NCEP plans to make continued progress by using emerging scientific developments and pursuing the powerful combination of cholesterol lowering in CHD patients and in primary prevention.Keywords
This publication has 18 references indexed in Scilit:
- Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Demographic, physical, dietary and biochemical characteristicsPublished by Elsevier ,2004
- Consistency between US dietary fat intake and serum total cholesterol concentrations: the National Health and Nutrition Examination SurveysThe American Journal of Clinical Nutrition, 1997
- Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trialsPublished by American Medical Association (AMA) ,1997
- Cardiovascular Health Risks Related to OverweightJournal of the American Dietetic Association, 1997
- Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research GroupPublished by American Medical Association (AMA) ,1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment PanelPublished by American Medical Association (AMA) ,1993
- Cholesterol lowering as a treatment for established coronary heart disease.Circulation, 1992
- Cholesterol in the Prediction of Atherosclerotic DiseaseAnnals of Internal Medicine, 1979